Endometriosis and Opioid Receptors: Are Opioids a Possible/Promising Treatment for Endometriosis?
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24021633 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Qihui Guan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology Charité with Center of Oncological Surgery, Endometriosis Research Center Charité, Campus Virchow-Klinikum, Augustenburger P…. Hauptthemen laut MEDLINE: Receptors, Opioid, Endometriosis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, German Research Foundation (DFG), OpenAccess Publication Fund of Charité—Universitätsmedizin Berlin.
Abstract (Originalsprache)
Endometriosis (EM), defined as the presence of endometrial-like tissue with surrounding smooth muscle cells outside the uterus, is a disregarded gynecological disease reported to affect 6–10% of women of reproductive age, with 30–50% of them suffering from chronic pelvic pain and infertility. Since the exact pathogenic mechanisms of EM are still unclear, no curative therapy is available. As pain is an important factor in EM, optimal analgesia should be sought, which to date has been treated primarily with non-steroidal anti-inflammatory drugs (NSAIDs), metamizole or, in extreme cases, opioids. Here, we review the pain therapy options, the mechanisms of pain development in EM, the endogenous opioid system and pain, as well as the opioid receptors and EM-associated pain. We also explore the drug abuse and addiction to opioids and the possible use of NOP receptors in terms of analgesia and improved tolerability as a target for EM-associated pain treatment. Emerging evidence has shown a promising functional profile of bifunctional NOP/MOP partial agonists as safe and nonaddictive analgesics. However, until now, the role of NOP receptors in EM has not been investigated. This review offers a thought which still needs further investigation but may provide potential options for relieving EM-associated pain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology Charité with Center of Oncological Surgery, Endometriosis Research Center Charité, Campus Virchow-Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany.
ORCID-Profile: Jalid Sehouli
Förderung
- Deutsche Forschungsgemeinschaft
- German Research Foundation (DFG)
- OpenAccess Publication Fund of Charité—Universitätsmedizin Berlin
Zitieren
APA
Guan, Q., Velho, R. V., Sehouli, J., & Mechsner, S. (2023). Endometriosis and Opioid Receptors: Are Opioids a Possible/Promising Treatment for Endometriosis?. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24021633
Vancouver
Guan Q, Velho RV, Sehouli J, Mechsner S. Endometriosis and Opioid Receptors: Are Opioids a Possible/Promising Treatment for Endometriosis?. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24021633
BibTeX
@article{Guan2023,
author = {Guan, Qihui and Velho, Renata Voltolini and Sehouli, Jalid and Mechsner, Sylvia},
title = {Endometriosis and Opioid Receptors: Are Opioids a Possible/Promising Treatment for Endometriosis?},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24021633}
}
EUVIMED